Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glutathione S-transferase polymorphisms and onset age in alpha-synuclein A53T mutant Parkinson's disease.
Golbe LI, Di Iorio G, Markopoulou K, Athanassiadou A, Papapetropoulos S, Watts RL, Vance JM, Bonifati V, Williams TA, Spychala JR, Stenroos ES, Johnson WG. Golbe LI, et al. Among authors: papapetropoulos s. Am J Med Genet B Neuropsychiatr Genet. 2007 Mar 5;144B(2):254-8. doi: 10.1002/ajmg.b.30450. Am J Med Genet B Neuropsychiatr Genet. 2007. PMID: 17034008
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Krüger R, Rocca WA, Schneider NK, Lesnick TG, Lincoln SJ, Hulihan MM, Aasly JO, Ashizawa T, Chartier-Harlin MC, Checkoway H, Ferrarese C, Hadjigeorgiou G, Hattori N, Kawakami H, Lambert JC, Lynch T, Mellick GD, Papapetropoulos S, Parsian A, Quattrone A, Riess O, Tan EK, Van Broeckhoven C; Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. Maraganore DM, et al. Among authors: papapetropoulos s. JAMA. 2006 Aug 9;296(6):661-70. doi: 10.1001/jama.296.6.661. JAMA. 2006. PMID: 16896109
FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.
Wider C, Dachsel JC, Soto AI, Heckman MG, Diehl NN, Yue M, Lincoln S, Aasly JO, Haugarvoll K, Trojanowski JQ, Papapetropoulos S, Mash D, Rajput A, Rajput AH, Gibson JM, Lynch T, Dickson DW, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA. Wider C, et al. Among authors: papapetropoulos s. Mov Disord. 2009 Feb 15;24(3):455-9. doi: 10.1002/mds.22442. Mov Disord. 2009. PMID: 19133659 Free PMC article.
Expression of alpha-synuclein mRNA in Parkinson's disease.
Papapetropoulos S, Adi N, Mash DC, Shehadeh L, Bishopric N, Shehadeh L. Papapetropoulos S, et al. Mov Disord. 2007 May 15;22(7):1057-9; author reply 1057. doi: 10.1002/mds.21466. Mov Disord. 2007. PMID: 17373725 No abstract available.
Phenotypic associations of tau and ApoE in Parkinson's disease.
Papapetropoulos S, Farrer MJ, Stone JT, Milkovic NM, Ross OA, Calvo L, McQuorquodale D, Mash DC. Papapetropoulos S, et al. Neurosci Lett. 2007 Mar 6;414(2):141-4. doi: 10.1016/j.neulet.2006.12.008. Epub 2007 Jan 3. Neurosci Lett. 2007. PMID: 17204369
Clinical characteristics of late-onset Parkinson disease.
Papapetropoulos S, Argyriou AA, Ellul J. Papapetropoulos S, et al. Arch Neurol. 2003 Dec;60(12):1815-6; reply 1816. doi: 10.1001/archneur.60.12.1815. Arch Neurol. 2003. PMID: 14676067 No abstract available.
172 results